Robert J Kowalik1, Anna Fojt1, Krzysztof Ozierański2, Michał Peller1, Paweł Andruszkiewicz3, Marek Banaszewski4, Marek Gierlotka5, Elżbieta Kremis6, Janina Stępińska4, Beata Średniawa7, Barbara Zawiślak8, Łukasz Kołtowski1, Marcin Grabowski1, Grzegorz Opolski1. 1. 1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland 2. 1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland. krzysztof.ozieranski@gmail.com 3. 2nd Department of Anesthesiology and Intensive Care, Central Teaching Hospital, Medical University of Warsaw, Warsaw, Poland 4. Intensive Cardiac Therapy Clinic, Institute of Cardiology, Warsaw, Poland 5. Department of Cardiology, University Hospital, Institute of Medicine, Faculty of Natural Sciences and Technology, University of Opole, Poland; 3rd Department of Cardiology, Silesian Centre for Heart Diseases, Zabrze, Poland 6. Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland 7. Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland; Silesian Center for Heart Diseases, Zabrze, Poland 8. 2nd Department of Clinical Cardiology and Cardiovascular Interventions,The University Hospital in Krakow, Kraków, Poland
Abstract
BACKGROUND: Targeted temperature management (TTM) is used to treat patients after sudden out‑of‑hospital cardiac arrest (OHCA). AIMS: The aim of the study was to compare the results of TTM between intensive general and cardiac care units (ICCUs). METHODS: The Polish Registry of Therapeutic Hypothermia obtained data on 377 patients with OHCA from 26 centers (257 and 120 patients treated at the ICCU and intensive care unit [ICU], respectively). Eligibility for TTM was based on the current inclusion criteria for therapy. Medical history as well as data on TTM and additional treatment were analyzed. The main outcomes included in‑hospital survival and complications as well as neurologic assessment using the Glasgow Coma Scale (GCS) and Rankin scale. RESULTS: Both ICU and ICCU patients were mostly male (mean age, 60 years). There were no significant differences regarding the medical history, mechanism of arrhythmia responsible for OHCA, GCS score on admission, time of cardiopulmonary resuscitation activities, and the time to target temperature (33°C). Coronary angiography and the use of dual antiplatelet therapy, intra‑aortic balloon pump, intravascular hypothermia, dopamine, and dobutamine were more common in ICCU patients, while ICU patients more often received norepinephrine. Pneumonia and acute renal failure were more frequent in the ICCU group. Death occurred in 17% and 20% of ICU and ICCU patients, respectively (P = 0.57). The Rankin class after 48 hours since discontinuation of sedation and at discharge was comparable between groups. CONCLUSIONS: The ICCU has become a considerable alternative to the ICU to treat OHCA patients with TTM.
BACKGROUND: Targeted temperature management (TTM) is used to treat patients after sudden out‑of‑hospital cardiac arrest (OHCA). AIMS: The aim of the study was to compare the results of TTM between intensive general and cardiac care units (ICCUs). METHODS: The Polish Registry of Therapeutic Hypothermia obtained data on 377 patients with OHCA from 26 centers (257 and 120 patients treated at the ICCU and intensive care unit [ICU], respectively). Eligibility for TTM was based on the current inclusion criteria for therapy. Medical history as well as data on TTM and additional treatment were analyzed. The main outcomes included in‑hospital survival and complications as well as neurologic assessment using the Glasgow Coma Scale (GCS) and Rankin scale. RESULTS: Both ICU and ICCU patients were mostly male (mean age, 60 years). There were no significant differences regarding the medical history, mechanism of arrhythmia responsible for OHCA, GCS score on admission, time of cardiopulmonary resuscitation activities, and the time to target temperature (33°C). Coronary angiography and the use of dual antiplatelet therapy, intra‑aortic balloon pump, intravascular hypothermia, dopamine, and dobutamine were more common in ICCU patients, while ICU patients more often received norepinephrine. Pneumonia and acute renal failure were more frequent in the ICCU group. Death occurred in 17% and 20% of ICU and ICCU patients, respectively (P = 0.57). The Rankin class after 48 hours since discontinuation of sedation and at discharge was comparable between groups. CONCLUSIONS: The ICCU has become a considerable alternative to the ICU to treat OHCA patients with TTM.
Authors: Robert Kowalik; Marek Gierlotka; Krzysztof Ozierański; Przemysław Trzeciak; Anna Fojt; Piotr Feusette; Agnieszka Tycińska; Grzegorz Opolski; Marcin Grabowski; Mariusz Gąsior Journal: J Clin Med Date: 2022-01-26 Impact factor: 4.241